Clin

What is the most important question to ask in early phase clinical drug development?

  • Chair(s):

    Dr. Geert Jan Groeneveld,
    CSO/CMO,Centre for Human Drug Research, Leiden, The Netherlands

    Prof. Adam Cohen CSO/CMO,Centre for Human Drug Research, Leiden, The Netherlands

  • Session description:

    Question based drug development
    Professor Adam Cohen1 1 CSO/CMO, Centre for Human Drug Research, Leiden, The Netherlands

    De-risking FIH studies
    Dr Jules Heuberger
    Senior Clinical Scientist, Centre for Human Drug Research, Leiden, The Netherlands

    Proof-of-pharmacology in early phase clinical drug studies
    Dr Geert Jan Groeneveld
    CSO/CMO,Centre for Human Drug Research, Leiden, The Netherlands

    Accelerated proof-of-concept in early clinical development
    Dr Robert Rissmann
    Research Director, Centre for Human Drug Research, Leiden, The Netherlands

    Analysis of wearables generated data as pharmacological biomarkers using AI
    Ahnjili Zhuparris
    Product manager trial@home,Centre for Human Drug Research, Leiden, The Netherlands

  • Sponsored by:

    the British Journal of Clinical Pharmacology

  • 00

    days

  • 00

    hours

  • 00

    minutes

  • 00

    seconds

Speakers

Leave A Comment

Go to Top